Correlation Between IShares Global and Genetic Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Global and Genetic Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Global and Genetic Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Global Healthcare and Genetic Technologies, you can compare the effects of market volatilities on IShares Global and Genetic Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Global with a short position of Genetic Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Global and Genetic Technologies.

Diversification Opportunities for IShares Global and Genetic Technologies

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between IShares and Genetic is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding iShares Global Healthcare and Genetic Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genetic Technologies and IShares Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Global Healthcare are associated (or correlated) with Genetic Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genetic Technologies has no effect on the direction of IShares Global i.e., IShares Global and Genetic Technologies go up and down completely randomly.

Pair Corralation between IShares Global and Genetic Technologies

Assuming the 90 days trading horizon iShares Global Healthcare is expected to generate 0.12 times more return on investment than Genetic Technologies. However, iShares Global Healthcare is 8.38 times less risky than Genetic Technologies. It trades about 0.04 of its potential returns per unit of risk. Genetic Technologies is currently generating about -0.1 per unit of risk. If you would invest  13,401  in iShares Global Healthcare on October 14, 2024 and sell it today you would earn a total of  629.00  from holding iShares Global Healthcare or generate 4.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

iShares Global Healthcare  vs.  Genetic Technologies

 Performance 
       Timeline  
iShares Global Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iShares Global Healthcare has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward-looking indicators, IShares Global is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Genetic Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genetic Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Genetic Technologies is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

IShares Global and Genetic Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Global and Genetic Technologies

The main advantage of trading using opposite IShares Global and Genetic Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Global position performs unexpectedly, Genetic Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genetic Technologies will offset losses from the drop in Genetic Technologies' long position.
The idea behind iShares Global Healthcare and Genetic Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon